|
|
Volumn 29, Issue 9, 2002, Pages 1206-1211
|
|
Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21
a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c |
|
Author keywords
Head and neck cancer; Hypoxia; Pimonid azole; SPET
|
|
Indexed keywords
BRU 59 21 TC 99M;
PIMONIDAZOLE;
RADIOPHARMACEUTICAL AGENT;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG DISTRIBUTION;
DRUG SAFETY;
DRUG UPTAKE;
ERYTHEMA;
FEMALE;
HEAD AND NECK CANCER;
HUMAN;
HYPOXIA;
IMAGE ANALYSIS;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE;
MALE;
MEDICAL ASSESSMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PAIN;
PHASE 1 CLINICAL TRIAL;
RADIOACTIVITY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
VERTIGO;
XEROSTOMIA;
CELL HYPOXIA;
COMBINED MODALITY THERAPY;
HEAD AND NECK NEOPLASMS;
HUMANS;
INJECTIONS, INTRAVENOUS;
LARYNGEAL NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
NEOPLASM STAGING;
NITROIMIDAZOLES;
NORMAL DISTRIBUTION;
ORGANOTECHNETIUM COMPOUNDS;
RADIATION-SENSITIZING AGENTS;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, EMISSION-COMPUTED;
|
|
EID: 0036373462
PISSN: 03406997
EISSN: None
Source Type: Journal
DOI: 10.1007/s00259-002-0888-0 Document Type: Article |
|
Times cited : (29)
|
|
References (14)
|
